← All diseases
Brain and nervous system
Progressive supranuclear palsy (PSP)
Would you like to receive a message when new research about Progressive Supranuclear Palsy (PSP) is available? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll be notified as soon as there is new research on Progressive Supranuclear Palsy (PSP). View what Premium costs.
Publications and studies (1195)
- Striatal Tau Pathology Underlies Monoaminergic Disruption in Progressive Supranuclear Palsy. (2026/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Dramatic sex differences leading to different brain disease presentation: The requirement for sex-specific medications with ADNP/davunetide as a case study. (2026/08/10) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Early-Onset Parkinson's Disease with 22q11.2 Microdeletion and Pathogenic GBA1 Variant. (2026/08/10) ♡
- The hummingbird sign in progressive supranuclear palsy. (2026/08/05) ♡
- Patterns of iron deposition and classification in parkinsonian syndromes: a quantitative susceptibility mapping study. (2026/08/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Quantitative susceptibility mapping in neurodegenerative diseases: An umbrella review of iron-related biomarkers and mechanisms. (2026/08/03) ♡
- Correction to: Evaluation of disproportionately enlarged subarachnoid-space hydrocephalus in progressive supranuclear palsy. (2026/08/03) ♡
- Wearable gait analysis for differentiating progressive supranuclear palsy and Parkinson's disease: Clinically interpretable digital biomarkers using machine learning. (2026/08/03) ♡
- Immune system modifications in atypical parkinsonism related to autoimmunity - a case control study. (2026/08/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Increased 18 F-AV1451 Retention in Soft Tissue of Patients With Progressive Supranuclear Palsy. (2026/08/01) ♡
- Diagnostic, Prognostic Value, and Pathological Associations of Levodopa Responsiveness in Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy. (2026/08/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Visible Tongue Fasciculations With Electromyographic Denervation in Autopsy-Proven Progressive Supranuclear Palsy Mimicking Amyotrophic Lateral Sclerosis. (2026/08/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pathology and Genetics in a Global Cohort of Parkinsonian Disorders. (2026/08/01) ♡
- Metabolomic signatures supporting clinical stratification of Parkinson disease and atypical parkinsonism. (2026/08/01) ♡
- Development of a dynamics-enhanced facial algorithm to discriminate progressive supranuclear palsy (PSP) from Parkinson's disease (PD). (2026/08/01) ♡
- Multimodel Diffusion MRI Signatures in Atypical Parkinsonian Disorders. (2026/08/01) ♡
- Temporal order of clinical, imaging, and biomarker changes in frontotemporal lobar degeneration-associated syndromes. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. CD8(+) T lymphocytes in progressive supranuclear palsy and corticobasal degeneration: Interactions with tau pathology and neuroinflammation. (2026/07/30) ♡
- Early assessment, diagnosis and treatment of Parkinsonism and Related Syndromes study (ExPRESS): a protocol for an observational study on incident parkinsonism. (2026/07/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. From clinical phenotypes to molecular precision: multimodal biomarkers for progressive supranuclear palsy. (2026/07/27) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Late-onset PSP/FTD-like atypical parkinsonism as a novel phenotype of POLG-related disease: a case report. (2026/07/27) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial for "Substantia Nigra Susceptibility-to-Volume Ratio Derived from QSM as a Marker for Discrimination of Progressive Supranuclear Palsy from Parkinson's Disease and Multiple System Atrophy". (2026/07/24) ♡
- Plasma LC-HRMS metabolomics in parkinsonian syndromes: comparative evaluation of sample preparation protocols for exploratory metabolic signatures. (2026/07/24) ♡
- Peripheral and central inflammation in progressive supranuclear palsy syndrome: an immunological and imaging neuroinflammation study. (2026/07/23) ♡
- Substantia Nigra Susceptibility-To-Volume Ratio Derived From QSM as a Marker for Discrimination of Progressive Supranuclear Palsy From Parkinson's Disease and Multiple System Atrophy. (2026/07/20) ♡
- Red blood cell-derived parameters as a potential tool in the differential diagnosis of parkinsonian syndromes. (2026/07/19) ♡
- Utility of the Short Cognitive and Neuropsychiatric Assessment Scale (ShoCo) in a multiethnic Asian cohort of patients with progressive supranuclear palsy. (2026/07/17) ♡
- Blood-based immunophenotyping of T cell profiles in patients with neurodegenerative disorders. (2026/07/16) ♡
- Cerebrovascular Single-Nucleus RNA-Seq Reveals Heat Shock Activation and Vascular Remodeling in Alzheimer's Disease and Primary Tauopathies. (2026/07/13) ♡
- Analytical and clinical validation of a novel proximity extension assay-based plasma biomarker panel in a cohort of prevalent neurodegenerative dementias. (2026/07/11) ♡
- Remote network for cognitive symptoms derived from tau accumulation in progressive supranuclear palsy. (2026/07/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Astrocyte epigenetics in development, aging, and neurodegeneration: a DNA methylation perspective. (2026/07/10) ♡
- PSP-specific atrophy targets regions connecting the salience network and subcortical circuits. (2026/07/09) ♡
- Evaluating MAPT p.A152T as a risk factor for the 3R tauopathy Pick's disease. (2026/07/09) ♡
- Caudate-Predominant Striatal Dopaminergic Deficit Distinguishes Behavioral Variant of Frontotemporal Dementia With Parkinsonism From Other Parkinsonian Syndromes. (2026/07/08) ♡
- Global Rather Than Vertical-Selective Saccadic Abnormalities in Progressive Supranuclear Palsy. (2026/07/07) ♡
- In-clinic validation of a smartphone-based finger tapping test for use in neurodegenerative and neurological populations. (2026/07/07) ♡
- The association between body composition and orthostatic hypotension in patients with neurodegenerative disorders in parkinsonism-related multidisciplinary clinic. (2026/07/07) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. A sacred prelude to aphasia: Demystifying a diagnostic trinity. (2026/07/06) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Limb apraxia in Parkinson's disease and atypical parkinsonian syndromes: a systematic review. (2026/07/04) ♡
- Regional mapping of CSF1R-positive microglia in neurodegenerative diseases and progressive MS, with exploratory presynaptic marker analyses. (2026/07/04) ♡
- Semiquantitative [¹²³I]FP-CIT SPECT metrics combined with machine learning improve clinical differentiation of Parkinson's disease and atypical parkinsonian syndrome. (2026/07/03) ♡
- Opposite molecular sex correlations in tauopathy paralleled by motor and cognitive efficacy of davunetide in women. (2026/07/03) ♡
- [Rare hereditary and acquired diseases with parkinson's syndrome]. (2026/07/02) ♡
- Predicting pattern and spread of brain atrophy and tau deposition in progressive supranuclear palsy. (2026/07/02) ♡
- Polyneuropathy in Parkinson's disease and atypical Parkinsonian syndromes: clinical impact and risk factors. (2026/07/01) ♡
- Distinct plasma inflammatory signatures reflect disease severity and progression in progressive supranuclear palsy: a prospective cohort study. (2026/07/01) ♡
- Shortening the SWAL-QOL: Is it possible to create a valid short form? (2026/07/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Longitudinal cognitive outcomes in two progressive supranuclear palsy clinical trials. (2026/07/01) ♡
- Structural MRI Volumetry Index for Differentiation of Progressive Supranuclear Palsy From Parkinson's Disease and Multiple System Atrophy by Automatic Segmentation: A Comparison With Magnetic Resonance Parkinsonism Index. (2026/07/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.